Truist Financial Corp Co Diagnostics, Inc. Transaction History

Truist Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$5.03 - $9.61 $88,025 - $168,175	-17,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $405 - $518	-50 Reduced 0.28%	17,500 $156,000
Q3 2021 Nov 05, 2021	SELL	$7.48 - $11.38 $1,084 - $1,650	-145 Reduced 0.82%	17,550 $171,000
Q2 2021 Aug 16, 2021	SELL	$7.16 - $9.56 $207 - $277	-29 Reduced 0.16%	17,695 $146,000
Q1 2021 May 17, 2021	BUY	$8.52 - $19.21 $151,008 - $340,478	17,724 New	17,724 $169,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.